A collaboration between:
2020 Prostate Cancer Highlight - The Prostate Cancer Clinical Trials Consortium: Addressing Health Disparities by Increasing Diversity in Clinical Trials, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study | Request PDF
Travis Gerke
Prostate Cancer Clinical Trial Consortium (PCCTC) | Florence - Florence
The PCCTC (@ThePCCTC) / Twitter
Prostate Cancer Clinical Trial Consortium (PCCTC) | Florence - Florence
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN) - European Urology
The Prostate Cancer Clinical Trials Consortium (PCCTC) | LinkedIn
Operational Strategies for Clinical Trials in Africa | JCO Global Oncology
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News
Advancing Prostate Cancer Research - The Prostate Cancer Clinical Trials Consortium (PCCTC) - Sarah Wise
PCCTC
jake vinson (@vjake20) / Twitter
Movember - Networks
Leading Prostate Cancer Research Organization Partners with Florence - Florence
Prostate Cancer Clinical Trial Consortium (PCCTC) | Florence - Florence
The PCCTC (@ThePCCTC) / Twitter
PDF) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium | Mitchell Gross - Academia.edu
COMPPARE Study Highlighted in Cancer Connections Presentation » COMPPARE
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
PCCTC
